TheHappyChemical
Bluelighter
- Joined
- May 27, 2007
- Messages
- 57
I'm wondering what are the potential results of such a combination as far as neurotoxicity go.
Would the suppressed dopamine release from 5-HT2C agonism, coupled with the serotonin reuptake inhibition, stopping dopamine from being uptaken by SERT reduce the risk? Would serotonin syndrome be a problem from so much action? I've read its mostly mediated by the 5-HT2B receptor site being overwhelmed.
Note the chemicals in question are 2c-b(which is thought to be a partial agonist/possible full antagonist of 5-HT2B as well) for the 5-HT2C agonist, and methylone and/or mephedrone for the Serotonin/DA reuptake inhibition and release.
Would the suppressed dopamine release from 5-HT2C agonism, coupled with the serotonin reuptake inhibition, stopping dopamine from being uptaken by SERT reduce the risk? Would serotonin syndrome be a problem from so much action? I've read its mostly mediated by the 5-HT2B receptor site being overwhelmed.
Note the chemicals in question are 2c-b(which is thought to be a partial agonist/possible full antagonist of 5-HT2B as well) for the 5-HT2C agonist, and methylone and/or mephedrone for the Serotonin/DA reuptake inhibition and release.
